Ana Komparic
Overview
Explore the profile of Ana Komparic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
12
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Komparic A, Garon-Sayegh P, Bensimon C
Bioethics
. 2023 Feb;
37(4):406-415.
PMID: 36789539
Codes of medical ethics (codes) are part of a longstanding tradition in which physicians publicly state their core values and commitments to patients, peers, and the public. However, codes are...
2.
Boulanger R, Komparic A, Dawson A, Upshur R, Silva D
J Bioeth Inq
. 2019 Dec;
17(1):65-73.
PMID: 31858386
Objective: To identify the ethical challenges associated with the development and implementation of new tuberculosis (TB) drugs and diagnostics. Methods: Twenty-three semi-structured qualitative interviews conducted between December 2015 and September...
3.
Komparic A, Dawson A, Boulanger R, Upshur R, Silva D
Bioethics
. 2019 Jan;
33(5):557-567.
PMID: 30681168
Prominent tuberculosis (TB) actors are invoking solidarity to motivate and justify collective action to address TB, including through intensified development and implementation (D&I) of technologies such as drugs and diagnostics....
4.
Komparic A, Smith M, Thompson A
Public Health Ethics
. 2016 Mar;
9(1):78-91.
PMID: 26955399
Health regulators must carefully monitor the real-world safety and effectiveness of marketed vaccines through post-market monitoring in order to protect the public's health and promote those vaccines that best achieve...
5.
Komparic A
Bioethics
. 2015 Oct;
29(9):604-12.
PMID: 26481201
A growing number of countries in sub-Saharan Africa are considering legalizing the growth of genetically modified organisms (GMOs). Furthermore, several projects are underway to develop transgenic crops tailored to the...
6.
Thompson A, Komparic A, Smith M
Vaccine
. 2014 Dec;
32(52):7171-4.
PMID: 25454882
The objective of this paper is to identify and articulate ethical considerations to help guide decision-making around the regulation and monitoring of vaccines post-licensure. While these considerations are not intended...